Robert Lovegrove, Vice President of Corporate Strategy at Milliken & Company

When it comes to billion-dollar deals, success depends less on how much analysis is done and more on how clearly the organization aligns around what truly matters.

In this episode of the M&A Science Podcast, Robert Lovegrove, President & CEO of The ChemQuest Group Inc. Previously, as VP of Corporate Strategy at Milliken & Company, shares how one of the company’s largest acquisitions was shaped by focus, discipline, and internal alignment. Rather than overwhelming the process with more diligence, leadership centered the decision around four core questions that clarified risk, built conviction, and guided a confident go / no-go decision.

Robert also explains how adjacency-based M&A reduced execution risk, why trust mattered more than price in winning the deal, and how treating culture as a deal consideration—rather than an integration afterthought—helped unlock long-term growth.

‍

What You’ll Learn:

• How to create executive alignment in high-stakes M&A decisions
• The four questions that anchor go / no-go decisions at scale
• Why adjacency-driven M&A improves confidence and execution
• How trust can outweigh price in competitive deal processes
• Why culture should be treated as a deal risk, not an HR issue

‍